Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives

Chimeric antigen receptor (CAR) T-cell therapy has significantly advanced the treatment of patients with relapsed and refractory hematologic malignancies and is increasingly investigated as therapeutic option of other malignancies. The main adverse effect of CAR T-cell therapy is potentially life-th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Coll Cardiol
Asıl Yazarlar: Ganatra, Sarju, Carver, Joseph R., Hayek, Salim S., Ky, Bonnie, Leja, Monika J., Lenihan, Daniel J., Lenneman, Carrie, Mousavi, Negaresh, Park, Jae H., Perales, Miguel Angel, Ryan, Thomas D., Scherrer-Crosbie, Marriele, Steingart, Richard M., Yang, Eric H., Zaha, Vlad, Barac, Ana, Liu, Jennifer E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8211027/
https://ncbi.nlm.nih.gov/pubmed/31856973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.10.049
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller